latest update:
[TrialBase DB]

trial summary · NCT07530536

rTMS for Postoperative Brain Tumor Patients

Repetitive Transcranial Magnetic Stimulation for Enhancing Motor Recovery in Postoperative Brain Tumor Patients

Trial record from the TrialBase DB dataset, status RECRUITING, condition Brain Tumors, sponsored by Brian J.Gill. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07530536phase —enrollment 6start 2027-01

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

When doctors perform surgery to remove brain tumors, the goal is to take out as much of the tumor as possible while keeping the patient's brain functions intact. However, sometimes patients have trouble with movements like walking or using their hands after surgery. One reason for this is unintentional damage to important areas of the brain during the operation. A technique called Transcranial Magnetic Stimulation (TMS) might help patients recover these lost abilities faster. The investigators are conducting a study to see if TMS can help patients recover their movement abilities after brain tumor surgery. TMS uses magnetic pulses to stimulate specific parts of the brain. In this study, the investigators will treat six patients with TMS once per day for three days in a row. Three patients with recent movement difficulties one to two weeks after surgery will be recruited for this study; they will also receive physical therapy. An additional three patients with persisting movement difficulties up to three years after tumor surgery will also be recruited for this study, regardless of whether or not they receive physical therapy. The investigators will use two standard tests to see how well patients can move before and after the TMS treatment. These tests will help the investigators understand if TMS is making a difference in their recovery.

Source record: https://clinicaltrials.gov/study/NCT07530536

Facts

registry idNCT07530536
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionBrain Tumors
sponsorBrian J.Gill
sponsor classOTHER
enrollment6
start date2027-01
primary completion2028-04
completion2028-04
results postednot reported

Conditions

  • Brain Tumors
  • Transcranial Magnetic Stimulation
  • Motor Deficit
  • Quality of Life

Interventions

  • Transcranial magnetic stimulation (TMS)

Countries

  • United States

Intervention types: DEVICE

Work with this record